BETRAYED BY THE VA Thomas Alan Bowman Sr. asked his country for help. He got silence. Sign the demand →
Dear Doug Collins

The Nehmer Class: A Widow's Name Forced the VA to Reopen a Generation of Denied Agent Orange Claims

The case is named for a widow. Beverly Nehmer stood first in the caption of a class action brought on behalf of all Vietnam veterans and their survivors who had been denied benefits for diseases they attributed to Agent Orange — and of everyone who would ever file such a claim in the future. What the class won was not a single payment but a machine: a court order, still running today, under which every time the VA concedes that another disease is connected to herbicide exposure, it must go back through its own files, find the claims it denied years or decades earlier, decide them again, and pay as if the original claim had been granted. This page is the record of the rule that made the denials necessary, the order that voided them, and the thirty-five years of enforcement it has taken to make the government keep its word.

The service and the promise

Between 1962 and 1971, in a program called Operation Ranch Hand, the U.S. Air Force sprayed nearly 19 million gallons of herbicides over Vietnam, of which at least 11 million gallons was Agent Orange — a mixture of two herbicides, one of them contaminated in manufacture with TCDD, a form of dioxin. The Institute of Medicine’s history of the program records those figures, and records as well that the number of American service members who served in Vietnam during the years of herbicide use is estimated at between 2.6 and 3.8 million. The spraying was done by aircraft, but also from helicopters, riverboats, trucks, and backpacks, around base perimeters and along roads and waterways. Exposure was not a specialty. It was the weather of the war for the generation that fought it — Army, Navy, Air Force, and Marines, on the ground, on the rivers, and, as later litigation would establish, in the waters offshore.

The promise made to that generation was the same one made to every American service member: that a disability incurred in service would be compensated, and that a family whose breadwinner died of a service-connected cause would not be left with nothing. For diseases that appear years after service, Congress has repeatedly supplied a shortcut: the presumption. If a veteran served in a defined place in a defined period and later develops a listed disease, the law presumes the connection and the veteran need not prove what cannot, decades later, be proved. Everything on this page turns on how the VA handled that presumption for the Agent Orange generation — first by narrowing it to almost nothing, and then, under court order, by being made to run it in reverse through its own archive of denials.

Military personnel were raising questions about the herbicides’ effects as early as 1967, as Judge William Alsup recorded in a 2020 order in this case, and the first claims asserting Agent Orange conditions reached the VA in 1977. The diseases at issue were cancers, diabetes, heart disease, and neurological disease, arriving in men in their thirties, forties, and fifties — and the survivors’ claims that followed when those men died.

What happened

Congress moved first, and the VA narrowed what Congress had done. On October 24, 1984, the Veterans’ Dioxin and Radiation Exposure Compensation Standards Act — the Dioxin Act — directed the VA to write regulations determining which diseases would be treated as service-connected for veterans exposed to dioxin in Vietnam. As the district court later summarized the statute, Congress intended service connection to rest on a finding of a significant statistical association between dioxin exposure and disease. The regulation the VA produced, 38 C.F.R. § 3.311a, effective September 25, 1985, took a different course. It presumed that a veteran who served in the Republic of Vietnam had been exposed to a herbicide containing dioxin. But in subsection (d) it recognized exactly one disease — chloracne, a skin condition — as sufficiently linked to that exposure to establish service connection, and it judged the evidence for every other disease against a standard the court would later describe as requiring proof of a causal relationship, a standard Congress had not enacted.

The practical consequence was a generation of denials. A veteran with soft-tissue sarcoma, a widow whose husband had died of lung cancer, a family confronting diabetes or heart disease — each claim ran into the same regulation, under which the scientific evidence was, by the agency’s own construction, never enough. The denials were not individual mistakes. They were the regulation working as written.

In 1986, attorneys from the National Veterans Legal Services Program, a nonprofit legal organization, filed suit challenging the regulation on behalf of Vietnam veterans and their survivors. The case was Nehmer v. U.S. Department of Veterans Affairs, No. C 86-6160, in the U.S. District Court for the Northern District of California, and Beverly Nehmer — the widow of a veteran — was its named plaintiff. On December 22, 1987, Judge Thelton E. Henderson certified the case as a class action on behalf of all service members, and their survivors, who were eligible to apply for benefits based on dioxin exposure or who had already applied and been denied, and certified NVLSP’s lawyers as counsel for the class. They hold that appointment still.

On May 3, 1989, Judge Henderson ruled. In the decision reported as Nehmer I, 712 F. Supp. 1404, the court invalidated 38 C.F.R. § 3.311a(d), holding that the VA had used too restrictive a standard — demanding cause-and-effect proof where Congress had directed a standard of statistical association — and the court voided all benefit decisions made under the invalidated subsection. The VA chose to comply rather than appeal, as NVLSP’s later testimony to the Senate Veterans’ Affairs Committee records. The denials of the late 1980s were, in law, erased. What remained was to build the machinery that would decide those claims again, and decide every future claim of the same kind.

What the institution did afterward

Congress rebuilt the science process, and the class built the payment machine. On February 6, 1991, the Agent Orange Act of 1991, Public Law 102-4, became law. It directed the VA to presume service connection for three diseases in veterans who served in the Republic of Vietnam — non-Hodgkin’s lymphoma, soft-tissue sarcomas, and chloracne — and it required the Secretary, whenever he determined that a positive association existed between herbicide exposure and another disease, to issue a regulation presuming that disease service-connected as well. To keep that determination honest, the Act put the science outside the agency: the National Academy of Sciences was charged with reviewing the evidence, with updates every two years. The standard Congress wrote was the one the court had vindicated — positive association, not proof of causation.

The Act, however, did not by itself reach backward. As Judge Alsup’s 2020 order in the case explains, nothing in it ensured that when a new disease was recognized, the claims previously denied for that disease would be re-decided. The consent decree did that. On May 17, 1991, the district court entered the Final Stipulation and Order in Nehmer — the decree. Its third paragraph provides that as soon as a final rule service-connects a disease based on dioxin exposure, the VA shall promptly readjudicate all claims for that disease that were voided by the 1989 order, together with similar claims filed afterward. Its fifth paragraph sets the money term: the effective date of an award on readjudication is the date the original claim was filed, or the date the disability arose or the death occurred, whichever is later. The veteran does not have to refile. The agency must come and find him — or find his widow, his child, or his estate.

Those rules now sit in the Code of Federal Regulations at 38 C.F.R. § 3.816, which states on its face that it sets out the effective-date rules required by the court’s orders in Nehmer, No. CV-86-6160 TEH. A Nehmer class member is a Vietnam veteran who has a covered herbicide disease, or the surviving spouse, child, or parent of a Vietnam veteran who died from one. If the VA denied compensation for the same disease in a decision issued between September 25, 1985 — the effective date of the voided regulation — and May 3, 1989, the award’s effective date is the later of the date the VA received the original claim or the date the disability arose; parallel rules govern survivors’ claims, and the regulation expressly overrides the ordinary statutory bar on paying benefits for periods before a presumption took effect. In plain terms: a claim denied in 1987 for a disease recognized in 2010 is paid as a 1987 claim.

The institution did not then simply comply, and the decree’s history since 1991 is a history of enforcement. In 1995 the VA’s General Counsel issued a precedent opinion under which retroactive payment was essentially limited to claimants who had themselves raised Agent Orange or whose denials had cited the voided regulation. Class counsel petitioned the court in 1998, citing two widows who had been granted benefits on new claims but refused retroactivity on their original ones. On February 11, 1999, in Nehmer II, 32 F. Supp. 2d 1175, Judge Henderson held that the VA’s method of identifying voided decisions was too formalistic: the 1989 order had voided decisions denying a disease later found associated with herbicide exposure, whether or not the claimant had invoked Agent Orange and whether or not the denial had cited the regulation. The Ninth Circuit affirmed the decree’s enforcement again in 2002, in litigation over retroactive benefits for prostate cancer and payment of accrued benefits to the estates of veterans who had died waiting. When the VA then argued that the decree did not reach diseases recognized after the Agent Orange Act’s original sunset date — it had declined on that theory to readjudicate claims for chronic lymphocytic leukemia, recognized in 2003 — the class moved again in 2004, and in 2005 the district court rejected the VA’s reading and clarified that the decree follows the life of the Act. The Ninth Circuit affirmed in 2007; the 2020 enforcement order quotes that opinion’s frustration back at the record — the court of appeals found it difficult to comprehend why the department, having agreed to the consent order, continued to resist both its implementation and the payment of benefits to veterans suffering from the government’s own conduct.

The fourth enforcement fight was the largest. For the decree’s first eleven years, the VA had readjudicated claims of veterans who held the Vietnam Service Medal — including sailors who served in Vietnam’s territorial waters, the Blue Water Navy. In 2002 the agency reversed itself and confined the presumption to those who had set foot on land or served on inland waterways. A separate case, Procopio v. Wilkie, later settled as a matter of statutory interpretation that the Agent Orange Act’s reference to service in the Republic of Vietnam reached the territorial seas; it did not decide what the decree required for claims already denied. That question came back to Nehmer. On November 5, 2020, Judge Alsup granted the class’s fourth motion to enforce the judgment, holding that the decree required the VA to automatically readjudicate the previously denied claims of Blue Water veterans and pay retroactive benefits where service in the territorial seas was shown. The VA announced it would comply, and in April 2021 it began readjudicating claims of veterans denied for lack of in-country service — without requiring any new claim — with benefits payable retroactively to the date of the previously denied claim, including to survivors and estates.

The cumulative result is the figure attached to this case. In November 2020, announcing the Blue Water enforcement order, NVLSP stated that as a result of the consent decree the VA had paid more than $4.6 billion in retroactive disability and death benefits to hundreds of thousands of Vietnam veterans and their surviving family members. That is the class counsel’s figure, stated here as NVLSP stated it in 2020; the 2020 court order itself records, without a total, that readjudications of hundreds of thousands of claims had produced billions of dollars in retroactive awards that might not otherwise have been paid.

Where it stands now

The decree is not a monument. It is a live obligation, and the recent record shows both it working and it being resisted. When Congress, in the National Defense Authorization Act for 2021, added three more diseases to the presumptive list — bladder cancer, hypothyroidism, and parkinsonism — the Nehmer machinery engaged: previously denied claims were to be identified and readjudicated, with retroactive payment, without action by the claimant. The PACT Act of 2022 then added hypertension and monoclonal gammopathy of undetermined significance, and extended presumptive exposure to further places — Thailand, Laos, Cambodia, Guam and American Samoa, and Johnston Atoll. The Nehmer rules themselves remain what § 3.816 says they are: rules for Vietnam veterans and their survivors, built on service in Vietnam during the period the VA defines as January 9, 1962 to May 7, 1975, now including the territorial seas. Claims resting on the newer locations travel under the ordinary effective-date rules, which are far less generous.

And the identification duty — the heart of the decree, the promise that the agency will find the claimant rather than wait to be found — is precisely where the most recent official accounting found failure. In a report issued in June 2024, the VA’s Office of Inspector General found that the Veterans Benefits Administration had not identified all the Vietnam veterans who could qualify for retroactive benefits after the 2021 additions. Working from health-system records the benefits administration had not used, the Inspector General estimated that of some 86,894 veterans with the newly added diseases in their VA medical records, about 36,125 were entitled to approximately $836.8 million in unpaid benefits. The VA concurred with two of the Inspector General’s three recommendations. Thirty-three years after the decree, tens of thousands of class members were still waiting to be found by the system the decree ordered to find them.

Outside the class definition, the older boundary still stands. The Nehmer class is a Vietnam-service class. Veterans exposed to herbicides where the chemicals were stored, tested, or sprayed at bases inside the United States — the Legion’s 2018 account names Fort Drum, New York, where the Army acknowledged herbicide use — are not within it, and the VA’s own guidance tells those veterans they must prove their individual exposure to obtain service connection for the presumptive diseases. Their claims proceed one at a time, without the decree’s automatic readjudication and without its retroactive reach. No new statute has been sought for the core class, because the core class’s instrument is the decree itself: NVLSP remains in place as court-appointed class counsel and watchdog, and the enforcement pattern of 1999, the early 2000s, and 2020 — motion, order, readjudication — remains the mechanism by which each new disease, and each new narrowing by the agency, is answered.

The ledger

The accounting, in three lines — what the record shows has been done, what it shows has not, and what is still being sought.

What has been done

What has not been done

What is being sought

The record, on video

The Nehmer litigation was fought in filings and orders, and little of it was filmed; what the camera record holds is the war and the long aftermath the decree answers — the spraying, the denials, the veterans’ own testimony, and the continuing fight over what the herbicides did. Four films: a documentary history from the New York Times’ Retro Report, the trailer for the PBS Independent Lens documentary on the herbicides’ continuing use, an Australian broadcaster’s film on the generation after exposure, and veterans describing their own exposure and the claims process in their own words.

The long shadow. Retro Report's documentary history of Agent Orange for the New York Times: the spraying, the official assurances, the veterans who came home sick, and the decades of dispute that followed. (The New York Times.)

The fight continues. The official trailer for The People vs. Agent Orange, the documentary broadcast on PBS's Independent Lens in 2021, following two women pressing the chemical industry over the herbicides' use in Vietnam and in the United States. (ktaverna2, the filmmakers' channel.)

The next generation. SBS Dateline's film on the children of the exposed — the legacy of dioxin as carried by families in Vietnam, the other half of the herbicides' human record. (SBS Dateline.)

In their own words. Vietnam veterans describe how they were exposed to Agent Orange and the health problems that followed, with guests explaining how veterans could seek help from the VA. (VeteransForumNetwork.)

Sources

Part of Betrayed, Not Forgotten — this site's accounting for the service members and veterans their own institutions failed. Videos are embedded from their publishers; nothing here is re-hosted.